# Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury

> **NCT00041717** · PHASE3 · COMPLETED · sponsor: **Acorda Therapeutics** · enrollment: 213 (actual)

## Conditions studied

- Spinal Cord Injury
- Muscle Spasticity

## Interventions

- **DRUG:** Fampridine-SR
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00041717
- **Lead sponsor:** Acorda Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2004-02
- **Final completion:** 2004-05
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2020-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00041717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00041717, "Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00041717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*